In contrast, in pancreatic cancer, expression of both CXCL10 and CXCR3 in tumor tissue has been correlated with a poor prognosis (Liu et al., 2011; Lunardi et al., 2014) mostly due to increased chemoresistance (Delitto et al., 2015). The gene discussed is CXCR3; the disease is neoplasm.